Clinical Proteomics 
Journal Title
- Clinical Proteomics
ISSN
- E 1559-0275 | P 1542-6416 | 1542-6416 | 1559-0275
Publisher
- Humana Press, Inc.
- Springer Nature
Listed on(Coverage)
| JCR | 2015-2019 |
|---|---|
| SJR | 2005-2019 |
| CiteScore | 2011-2019 |
| SCIE | 2016-2021 |
| SCOPUS | 2017-2020 |
| DOAJ | 2017-2019;2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | translational proteomics, molecular medicine |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY, CC0 |
| Copyrights | Yes |
| DOAJ Coverage |
|
| Subject(s) | Medicine |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts. A key feature of Clinical Proteomics is its commitment to rapid scientific review and timely publication of submitted manuscripts. This is achieved receiving and processing submissions online. As molecular medicine moves beyond genomics to proteomics, the goal becomes the characterization of the cellular circuitry and the understanding of the impact of disease and therapy on cellular networks. Clinical Proteomics provides a scholarly forum for novel scientific research in the field of translational proteomics. The journal places special emphasis on the application of proteomic technology to all aspects of clinical research. A key feature is its commitment to rapid scientific review and timely publication of submitted manuscripts.